1018.05 11.50 (1.14%)

40.38% Gain from 52W Low

145.7K NSE+BSE Volume

NSE 30 May, 2025 3:31 PM (IST)

US FDA Approval
Alembic Pharma receives US FDA approval for Bosutinib Tablets, with a market size of $291 million See details

Alembic Pharmaceuticals Ltd. Delivery Percentage and Volume Analysis for NSE and BSE as of 01 Jun, 2025

Alembic Pharmaceuticals Ltd. Delivery Traded Volume, Percentages, Week Average and Analysis for NSE and BSE as of 01 Jun, 2025

Delivery Stock Screeners